ClinicalTrials.Veeva
Menu

Find clinical trials for Pancreatic Cancer in Charlotte, NC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Adenocarcinoma
Cancer
Carcinoma
Colorectal Cancer
Non-Small-Cell Lung Carcinoma
Lung Cancer
Squamous Cell Carcinoma of Head and Neck

Pancreatic Cancer trials near Charlotte, NC, USA:

A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer

Zolbetuximab is being studied as a treatment for people with pancreatic cancer. Most people with pancreatic cancer...

Active, not recruiting
Metastatic Pancreatic Adenocarcinoma
Metastatic Pancreatic Cancer
Drug: nab-paclitaxel
Drug: gemcitabine

Phase 2

Astellas
Astellas

Charlotte, North Carolina, United States and 135 other locations

PK, and PD of SON-DP in participants with relapsed/refractory/intolerant to standard of care therapies, for advanced/ metastatic solid tumors...

Enrolling
Solid Tumor
Breast Cancer
Drug: SON-DP

Phase 1

Qurgen

Huntersville, North Carolina, United States of America and 4 other locations

The study is a multi-center, open-label, randomized active controlled study of subjects with locally advanced pancreatic adenocarcinoma whic...

Enrolling
Locally Advanced Pancreatic Cancer
Device: RenovoCath
Drug: nab-paclitaxel

Phase 3

RenovoRx

Charlotte, North Carolina, United States and 38 other locations

(with enzalutamide-naïve metastatic castration-resistant prostate cancer) will be randomized to receive either NUV-868 monotherapy, enzaluta...

Enrolling
Prostate Neoplasm
Advanced Solid Tumor
Drug: Enzalutamide
Drug: NUV-868

Phase 1, Phase 2

Nuvation Bio

Huntersville, North Carolina, United States of America and 30 other locations

is to evaluate the safety and tolerability of RMC-9805 as monotherapy and in combination with RMC-6236 in adults with KRAS G12D-mutant solid tumors...

Enrolling
Non-small Cell Lung Cancer (NSCLC)
Colorectal Cancer (CRC)
Drug: RMC-6236
Drug: RMC-9805

Phase 1

Revolution Medicines
Revolution Medicines

Huntersville, North Carolina, United States of America and 16 other locations

This is an open-label, multicenter, global Phase 2 basket study of entrectinib (RXDX-101) for the treatment of patients with solid tumors th...

Active, not recruiting
Breast Cancer
Neuroendocrine Tumors
Drug: Entrectinib

Phase 2

Roche
Roche

Charlotte, North Carolina, United States and 122 other locations

NUV-1511-01 is a first-in human, open- label, Phase 1/2 to evaluate the safety and efficacy of NUV-1511 in patients with advanced solid tumors...

Enrolling
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Advanced Solid Tumor
Drug: NUV-1511

Phase 1, Phase 2

Nuvation Bio

Huntersville, North Carolina, United States of America and 7 other locations

and antitumor activity of CUE-102 intravenous (IV) monotherapy in HLA-A\*0201 positive patients with WT1 positive recurrent/metastatic solid tumors...

Active, not recruiting
Gastric Cancer
Ovarian Cancer
Drug: CUE-102

Phase 1

Cue Biopharma

Huntersville, North Carolina, United States of America and 14 other locations

, metastatic castration-resistant prostate cancer (mCRPC), melanoma, pancreatic cancer, hepatocellular carcinoma (HCC), ov...

Enrolling
Epithelial Ovarian Cancer
Advanced Solid Tumor
Biological: lorigerlimab
Biological: vobramitamab duocarmazine

Phase 1

MacroGenics
MacroGenics

Huntersville, North Carolina, United States and 9 other locations

The purpose of this study is to find out whether the study drug, LY3537982, is safe and effective in cancer patients who have a specific gen...

Enrolling
Ovarian Neoplasms
Biliary Tract Neoplasms
Drug: Cetuximab
Drug: Cisplatin

Phase 1, Phase 2

Lilly
Lilly

Charlotte, North Carolina, United States and 49 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems